SCHEMBL14067494

SCHEMBL14067494

Cc1cc(C)c2nc(-c3ccc(N(C)C)cc3)cn2n1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APP P05067 17/20 0.47
PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14067306 0.86 APP (0.51) APPPARP1
SCHEMBL4925086 0.86 APP (0.47) APP
SCHEMBL4920006 0.86 APP (0.49) APPPARP1
SCHEMBL14076029 0.77 APP (0.60) APP
SCHEMBL14067491 0.74 APP (0.54) APP
SCHEMBL4914340 0.72 APP (0.52) APP
SCHEMBL4921510 0.72 APP (0.52) APP
SCHEMBL14067308 0.72 APP (0.52) APP
SCHEMBL14067490 0.71 APP (0.56) APP
SCHEMBL3970342 0.70 KDM4E (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080219922-A1 Alzheimer's Disease Imaging Agents EMORY UNIVERSITY 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219922-A1 Alzheimer's Disease Imaging Agents APP, PSEN1, MAPT APP 1/4885PARP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.